Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLXP
2751
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $612K | ﹤0.01% |
5,275
+800
| +18% | +$78K |
|
2752
Ardelyx
ARDX
$1.01B
| $608K | ﹤0.01% |
+47,000
| New | +$492K |
|
|
AHGP
2753
DELISTED
Alliance Holdings GP
AHGP
| $607K | ﹤0.01% |
23,300
+4,385
| +23% | +$107K |
|
2754
Kingstone Companies
KINS
$284M
| $606K | ﹤0.01% |
65,667
+20,167
| +44% | +$181K |
|
|
SOHO
2755
DELISTED
Sotherly Hotels
SOHO
| $602K | ﹤0.01% |
113,978
+11,478
| +11% | +$66.5K |
|
2756
NLI Holdings
NL
$329M
| $600K | ﹤0.01% |
152,600
+25,500
| +20% | +$90.2K |
|
|
ENFC
2757
DELISTED
Entegra Financial Corp.
ENFC
| $599K | ﹤0.01% |
32,600
+15,100
| +86% | +$268K |
|
2758
Taylor Devices
TAYD
$172M
| $598K | ﹤0.01% |
30,300
+2,900
| +11% | +$56K |
|
2759
The Bancorp
TBBK
$2.83B
| $594K | ﹤0.01% |
92,600
-70,200
| -43% | -$406K |
|
2760
Full House Resorts
FLL
$83.5M
| $593K | ﹤0.01% |
331,500
+41,200
| +14% | +$77.4K |
|
|
GMLP
2761
DELISTED
Golar LNG Partners LP
GMLP
| $589K | ﹤0.01% |
+30,000
| New | +$568K |
|
2762
Fate Therapeutics
FATE
$294M
| $587K | ﹤0.01% |
188,000
+7,300
| +4% | +$17.7K |
|
|
AUTO
2763
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $587K | ﹤0.01% |
33,000
-18,300
| -36% | -$294K |
|
2764
Agilent Technologies
A
$41.9B
| $584K | ﹤0.01% |
12,400
-406,600
| -97% | -$19M |
|
|
ECYT
2765
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $584K | ﹤0.01% |
+189,000
| New | +$589K |
|
2766
NanoViricides
NNVC
$34.9M
| $582K | ﹤0.01% |
17,215
+100
| +0.6% | +$3.31K |
|
2767
USA Compression Partners
USAC
$3.84B
| $582K | ﹤0.01% |
31,000
-52,800
| -63% | -$841K |
|
2768
TriMas Corp
TRS
$1.41B
| $579K | ﹤0.01% |
31,100
-53,900
| -63% | -$997K |
|
|
UMH
2769
UMH Properties
UMH
$1.39B
| $573K | ﹤0.01% |
48,100
-406,700
| -89% | -$4.91M |
|
|
FLOW
2770
DELISTED
SPX FLOW, Inc.
FLOW
| $569K | ﹤0.01% |
+18,400
| New | +$513K |
|
|
CTO
2771
CTO Realty Growth
CTO
$819M
| $568K | ﹤0.01% |
40,900
+23,585
| +136% | +$318K |
|
2772
ImmuCell
ICCC
$99.3M
| $567K | ﹤0.01% |
73,300
+9,100
| +14% | +$66.2K |
|
|
CWBC
2773
Community West Bancshares
CWBC
$706M
| $565K | ﹤0.01% |
35,600
+3,200
| +10% | +$48.4K |
|
|
RXDX
2774
DELISTED
Ignyta, Inc.
RXDX
| $565K | ﹤0.01% |
+89,900
| New | +$522K |
|
|
EPE
2775
DELISTED
EP Energy Corporation
EPE
| $564K | ﹤0.01% |
128,728
+85,528
| +198% | +$357K |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.